Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.

Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.

Item
http://www.wikidata.org/entity/Q33410348
Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive ReviewBacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic DiseasesThromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France.Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study.Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles.Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children : Splenectomy in ITP.Long-term results of splenectomy in adult chronic immune thrombocytopenia.Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect.Emerging drugs for immune thrombocytopenia (ITP).Clinical Practice Updates in the Management Of Immune Thrombocytopenia.Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience.Low Dose Rituximab in Chronic ITP: Still an Option in Resource Limited Settings.Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopeniaCost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
P2860

Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.

Item
http://www.wikidata.org/entity/Q33410348
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Rituximab versus splenectomy i ...... on of mortality and morbidity.
@ast
Rituximab versus splenectomy i ...... on of mortality and morbidity.
@en
type
label
Rituximab versus splenectomy i ...... on of mortality and morbidity.
@ast
Rituximab versus splenectomy i ...... on of mortality and morbidity.
@en
prefLabel
Rituximab versus splenectomy i ...... on of mortality and morbidity.
@ast
Rituximab versus splenectomy i ...... on of mortality and morbidity.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Rituximab versus splenectomy i ...... on of mortality and morbidity.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921